Amundi Prime Emerging Markets UCITS ETF DR (C) is a equity ETF from Amundi tracking the Emerging Markets index through physical replication. Domiciled in Luxembourg and launched in 2021, the fund manages about 736 M € and charges a TER of 0.10% — 10 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Amundi Prime Emerging Markets UCITS ETF DR (C) competes with 104 other products in the same class and region (Equity, Emerging markets): it ranks 43rd by fund size and 3rd by ongoing cost, with a TER of 0.10% against a group median of 0.25%. It has been listed since 2021, 5 years of track record.
On a €10,000 investment the TER costs 10 € a year, against 25 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 35.7% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| Taiwan Semiconductor Manufacturing Co. Ltd. | 13.6% |
| Samsung Electronics Co Ltd | 7.5% |
| SK Hynix Inc | 7.3% |
| Tencent Holdings Ltd | 2.6% |
| Alibaba Group Holding Ltd | 1.6% |
| MediaTek Inc | 1.5% |
| Delta Electronics Inc | 0.9% |
| HDFC Bank Limited | 0.7% |
| XETRA | PRAM | EUR |
| London Stock Exchange | PRAM | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.